Who We Help
Fractional CTO – Healthcare

You focus on innovation. We navigate the regulation.

Fractional CTO healthcare leadership sits at the intersection of innovation and regulation.

The organisations that succeed in this space are not just the ones with the best products — they are the ones that understand how to build, deploy, and scale technology within one of the most complex regulatory environments in the world.

At 2MG Healthcare, we work with two types of organisations that approach this challenge from different directions but share a common need: senior technology leadership with deep, practical experience in regulated healthcare environments.

AI Healthtech & Biotech Startups

Fractional CTO Healthcare Services

The Challenge for Healthtech Startups

You have built an AI product that works.
Now you need to deploy it in healthcare, and the landscape has changed. Patient data governance, NHS compliance frameworks, clinical safety standards, and enterprise procurement requirements create a complexity that most startup engineering teams have not faced before.

At the same time, hiring a full-time CTO too early can be expensive and slow you down. You need senior technical leadership that understands both AI infrastructure and regulated healthcare.

How We Help Startups

We provide fractional CTO healthcare leadership and platform engineering expertise designed for healthtech startups.

Working alongside your team, we advise on:
– Designing scalable and secure AI infrastructure
– Preparing your platform for DSPT and clinical safety compliance
– Architect systems that integrate with NHS clinical environments
– Support building the technical credibility investors and NHS expect
– Help avoid common architecture mistakes that can delay products
– Provide fractional CTO healthcare guidance as your product matures

Typical Startup Engagement

Most startup engagements begin with a platform architecture and NHS readiness review. From there, we work on a retained fractional CTO basis, providing ongoing technology leadership, architecture guidance, and regulatory support as your product matures.
Book a Startup Strategy Call
Contact Us
Introductory call only. No advice or client relationship is created.

PE-Backed Healthcare & Pharma Companies

The Challenge for PE-Backed Companies

You have acquired a portfolio of healthcare or pharma technology assets, and now the real work begins. Legacy platforms need modernising, cybersecurity posture needs strengthening, and multiple systems need integrating — all while maintaining regulatory compliance across DSPT, clinical safety standards, and MHRA requirements. Investment timelines are tight, and the technology leadership gap between acquisition and value creation is where deals stall. You need a senior technology leader who understands both the commercial pressures of PE-backed healthcare and the regulatory complexity of the NHS ecosystem. Fractional CTO healthcare leadership may help bridge that gap without the overhead of a permanent hire.

How We Help PE-Backed Companies

We provide fractional CTO healthcare leadership and platform engineering expertise for PE-backed portfolio companies.
Working alongside your leadership team, we advise on:
– Post-acquisition technology due diligence and integration planning
– Assess and strengthen cybersecurity posture across portfolio companies
– Modernise legacy healthcare platforms while maintaining compliance
– Design scalable architecture that supports commercial growth targets
– Navigate NHS procurement frameworks including G-Cloud and Dynamic Purchasing Systems
– Build the technical credibility needed for enterprise NHS contracts

Typical PE Engagement

Most PE engagements begin with a technology due diligence and integration assessment across the portfolio.

From there, we work on a retained fractional CTO healthcare basis, providing ongoing technology leadership, architecture governance, and regulatory compliance oversight aligned with your investment timeline and value creation plan.
Book a Strategy Call
Contact Us
Introductory call only. No advice or client relationship is created.
Fractional CTO Healthcare service

The NHS is the largest single-payer healthcare system in Europe, serving over 65 million patients across hundreds of Trusts, Integrated Care Boards, and commissioning bodies. For any technology company looking to serve this market, the path from working product to live clinical deployment runs through a series of frameworks, standards, and procurement processes that can take years to navigate without the right guidance.
Data Security and Protection Toolkit assessments, Clinical Safety Cases under DCB0129 and DCB0160, DTAC evaluations, MHRA Software as a Medical Device classification, G-Cloud listings, and Dynamic Purchasing Framework submissions — each carries its own requirements, timelines, and stakeholder expectations.

Beyond regulatory compliance, the technical challenges are equally demanding. Healthcare AI platforms must handle sensitive patient data under strict governance frameworks, integrate with legacy clinical systems using standards like HL7 and FHIR, connect with national infrastructure including NHS Spine and MESH, and operate within Secure Data Environments and Trusted Research Environments where clinical and research data must remain protected at every stage.
Building platforms that meet these requirements while remaining scalable, cost-effective, and ready for enterprise procurement is a challenge where fractional CTO healthcare experience can make a significant difference.

For healthtech startups, the challenge is typically building the right foundations.
Your AI works in the lab, but deploying it in a live NHS Trust means rethinking your architecture, your data governance, and your compliance posture. Moving fast is important, but moving in the wrong direction costs more than slowing down.

For PE-backed healthcare and pharma companies, the pressure is different but no less demanding. Acquisitions need integrating, legacy platforms need modernising, and cybersecurity posture needs strengthening — all while maintaining regulatory compliance and delivering commercial returns within tight investment horizons.

Whatever your starting point, our fractional CTO healthcare approach brings the same thing: hands-on technology leadership from someone who has done this before.

No theory.
No generic consulting frameworks.
Just practical experience applied to your specific challenge.

Frequently Asked Questions:

Q: What is a fractional CTO for healthtech?
A: A fractional CTO healthcare leader is a senior technology professional who works with your company on a part-time or retained basis, providing the same strategic guidance and technical leadership as a full-time CTO — but at a fraction of the cost. For healthtech companies, this means someone with deep experience in NHS compliance frameworks, clinical safety standards, and regulated healthcare environments.

Q: How does a fractional CTO help with NHS compliance?
A: We guide your team through the full spectrum of NHS compliance requirements including DSPT (Data Security and Protection Toolkit) assessments, clinical safety cases under DCB0129 and DCB0160, DTAC evaluations, and MHRA Software as a Medical Device classification. We also support G-Cloud listings and Dynamic Purchasing Framework submissions.

Q: What is the difference between a fractional CTO and a technology consultant?
A: A technology consultant typically delivers a report and leaves. A fractional CTO becomes part of your leadership team — attending board meetings, making architecture decisions, mentoring your engineering team, and taking accountability for technology outcomes over months or years.

Q: How long does a typical fractional CTO engagement last?
A: Most engagements start with a focused assessment (2-4 weeks) and then move to an ongoing retained relationship. For startups, this often continues through to Series A or B. For PE-backed companies, engagements typically align with the investment horizon — usually 18 to 36 months.

Q: Do you work with companies outside the UK?
A: Our primary expertise is in the UK healthcare ecosystem, particularly the NHS. However, we work with international healthtech companies that are looking to deploy products in the UK market or need guidance on UK regulatory frameworks.